July 12, 2025

CRARY Faces High Dividend Cut Risk: Act Now

CRARY investors should take note: recent analyses indicate that the company is at a substantial risk of cutting its dividend. While the allure of regular income can be tempting, the current financial landscape painted by CRARY’s performance suggests more…

Ant Group Eyes Haodf.com to Enhance Healthcare AI Services

Ant Group, backed by the tech giant Alibaba, is reportedly considering the acquisition of Haodf.com, a prominent online healthcare…

New Real Estate Commission Rules: What You Should Know

Understanding the New Real Estate Commission RulesAs the real estate industry evolves, fresh regulations are emerging to reshape how…

AstraZeneca Expands Imfinzi Lung Cancer Treatment Options

AstraZeneca’s Imfinzi has received an expanded label in the U.S. for the treatment of lung cancer, marking a significant…

Bayer’s Stock Rises After Court Victory Over Roundup

Bayer AG is experiencing a notable surge in the European stock markets following a favorable ruling in the ongoing…

Revolut Secures $45B Valuation from Secondary Share Sale

Revolut, a prominent player in the fintech industry, has made headlines by achieving a staggering $45 billion valuation following…

Kandi Technologies Sees 9% Revenue Growth Surge

Kandi Technologies, a prominent player in the electric vehicle market, has recently reported a noteworthy 9% increase in revenue,…

AvePoint Plans Second Listing in Singapore Stock Market

AvePoint, Inc., a renowned leader in data management and governance solutions, is reportedly preparing for its second listing in…

J.P. Morgan Downgrades Murphy Oil Amid Production Concerns

In a recent market update, J.P. Morgan has made headlines by downgrading Murphy Oil Corporation (MUR), citing a downbeat…

Nasdaq Soars 2% as Walmart Reaches New Highs

In an encouraging development for investors, both the Nasdaq and S&P 500 indices experienced a significant rise, highlighting improved…

TC BioPharm Achieves Nasdaq Compliance Milestone

TC BioPharm Limited, a pioneering company in the biopharmaceutical sector, has made headlines by regaining compliance with Nasdaq. This…